Cargando…
Enfermedad pulmonar obstructiva crónica: los pacientes en la vida real. Estudio LEONPOC
OBJECTIVE: The purpose of this study was to evaluate different characteristics of COPD patients according to phenotypes and GOLD guidelines.according to GesEPOC phenotypes and GOLD 2011 ABCD guidelines and pharmacological treatment agreement. DESIGN: Cross-sectional survey. LOCATION: COPD patients a...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876058/ https://www.ncbi.nlm.nih.gov/pubmed/28292581 http://dx.doi.org/10.1016/j.aprim.2017.01.002 |
_version_ | 1783473145592676352 |
---|---|
author | García García, Silvia Carazo Fernández, Luis Juan García, Javier Naveiro Rilo, José Cesáreo |
author_facet | García García, Silvia Carazo Fernández, Luis Juan García, Javier Naveiro Rilo, José Cesáreo |
author_sort | García García, Silvia |
collection | PubMed |
description | OBJECTIVE: The purpose of this study was to evaluate different characteristics of COPD patients according to phenotypes and GOLD guidelines.according to GesEPOC phenotypes and GOLD 2011 ABCD guidelines and pharmacological treatment agreement. DESIGN: Cross-sectional survey. LOCATION: COPD patients aged 40-85 from León were randomly selected from Primary Care database, MEDORA. PARTICIPANTS: 5222 eligible COPD patients were collected from MEDORA database. We calculated a sample size of 734 patients and finally studied 577 of them. MAIN MEASUREMENTS: Patientś clinical, functional and health related quality of life information were collected. Spirometry and postbroncodilator test were performed. RESULTS: A total of 577 patients were included in this study. 28.7% of them did not have a spirometry recorded in their files. 123 patients had a normal or non-obstructive spirometry pattern, so they were excluded from a COPD diagnostic. With regard to treatments, there was an overprescribing of inhaled steroids in patients from GOLD A and B groups, and also in patients with the called exacerbator phenotype (GesEPOC). CONCLUSION: Although there have been several published guidelines, management of COPD patients in real life should be improved. |
format | Online Article Text |
id | pubmed-6876058 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-68760582019-11-26 Enfermedad pulmonar obstructiva crónica: los pacientes en la vida real. Estudio LEONPOC García García, Silvia Carazo Fernández, Luis Juan García, Javier Naveiro Rilo, José Cesáreo Aten Primaria Originales OBJECTIVE: The purpose of this study was to evaluate different characteristics of COPD patients according to phenotypes and GOLD guidelines.according to GesEPOC phenotypes and GOLD 2011 ABCD guidelines and pharmacological treatment agreement. DESIGN: Cross-sectional survey. LOCATION: COPD patients aged 40-85 from León were randomly selected from Primary Care database, MEDORA. PARTICIPANTS: 5222 eligible COPD patients were collected from MEDORA database. We calculated a sample size of 734 patients and finally studied 577 of them. MAIN MEASUREMENTS: Patientś clinical, functional and health related quality of life information were collected. Spirometry and postbroncodilator test were performed. RESULTS: A total of 577 patients were included in this study. 28.7% of them did not have a spirometry recorded in their files. 123 patients had a normal or non-obstructive spirometry pattern, so they were excluded from a COPD diagnostic. With regard to treatments, there was an overprescribing of inhaled steroids in patients from GOLD A and B groups, and also in patients with the called exacerbator phenotype (GesEPOC). CONCLUSION: Although there have been several published guidelines, management of COPD patients in real life should be improved. Elsevier 2017-12 2017-03-11 /pmc/articles/PMC6876058/ /pubmed/28292581 http://dx.doi.org/10.1016/j.aprim.2017.01.002 Text en © 2017 Elsevier España, S.L.U. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Originales García García, Silvia Carazo Fernández, Luis Juan García, Javier Naveiro Rilo, José Cesáreo Enfermedad pulmonar obstructiva crónica: los pacientes en la vida real. Estudio LEONPOC |
title | Enfermedad pulmonar obstructiva crónica: los pacientes en la vida real. Estudio LEONPOC |
title_full | Enfermedad pulmonar obstructiva crónica: los pacientes en la vida real. Estudio LEONPOC |
title_fullStr | Enfermedad pulmonar obstructiva crónica: los pacientes en la vida real. Estudio LEONPOC |
title_full_unstemmed | Enfermedad pulmonar obstructiva crónica: los pacientes en la vida real. Estudio LEONPOC |
title_short | Enfermedad pulmonar obstructiva crónica: los pacientes en la vida real. Estudio LEONPOC |
title_sort | enfermedad pulmonar obstructiva crónica: los pacientes en la vida real. estudio leonpoc |
topic | Originales |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876058/ https://www.ncbi.nlm.nih.gov/pubmed/28292581 http://dx.doi.org/10.1016/j.aprim.2017.01.002 |
work_keys_str_mv | AT garciagarciasilvia enfermedadpulmonarobstructivacronicalospacientesenlavidarealestudioleonpoc AT carazofernandezluis enfermedadpulmonarobstructivacronicalospacientesenlavidarealestudioleonpoc AT juangarciajavier enfermedadpulmonarobstructivacronicalospacientesenlavidarealestudioleonpoc AT naveirorilojosecesareo enfermedadpulmonarobstructivacronicalospacientesenlavidarealestudioleonpoc |